Is uzedy safe?

Is Uzedy safe for long-term use?

Uzedy is risperidone extended-release injectable suspension used for schizophrenia in adults. Data from clinical trials and real-world reports show it has a similar safety profile to oral risperidone. Long-term exposure data remain limited, but patients on the monthly or bimonthly injections maintain consistent plasma levels. Monitoring for tardive dyskinesia, metabolic changes, and neuroleptic malignant syndrome remains necessary.

What side effects are patients reporting?

Common complaints include weight gain, injection-site reactions, and sedation. Moderate risk of prolactin elevation can lead to sexual dysfunction or galactorrhea. Moderate risk of hyperglycemia and dyslipidemia requires regular metabolic monitoring. Patients with pre-existing cardiovascular disease must watch for orthostatic hypotension and QT prolongation.

Can older adults use Uzedy safely?

Elderly patients with dementia-related psychosis face a black-box warning for increased mortality. The FDA advises against using any atypical antipsychotic for this population. Other elderly patients require dose adjustment and careful observation for heightened sensitivity to side effects.

When does the Uzedy patent expire?

The primary composition-of-matter patent for Uzedy expires in 2030. [1]
The manufacturer lists several secondary patents covering formulation and manufacturing methods that extend exclusivity until 2036. [1]

How does Uzedy compare with oral risperidone?

Uzedy provides consistent drug delivery without daily pills. It avoids first-pass metabolism and improves adherence in non-compliant patients. Safety signals are identical except for injection-site issues and plasma-level peaks that are lower than oral spikes.

How does Uzedy compare with Abilify Maintena?

Abilify Maintena is aripiprazole rather than risperidone. Uzedy has a more active metabolite than Abilify Maintena. Safety data show Uzedy may produce higher prolactin elevation than aripiprazole-based injectables.